Overview


According to FutureWise analysis the market for Cetiofur is expected to register a CAGR of 5.80% from 2023-2031.

Ceftiofur, a veterinarian drug, has been approved to treat a variety of conditions in pigs, red and dairy cattle as well as other animals. Ceftiofur Sodium is a third-generation cephalosporin antibiotic. It inhibits bacterial growth by attaching to and activating penicillin-binding proteins (PBPs), on bacterial mobile partitions. Ceftiofur Sodium, a semi-synthetic third-generation cephalosporin antibiotic, was developed for veterinary purposes. Ceftiofur sodium inhibits bacterial cell wall formation by binding to penicillin-binding protein (PBP), which is essential for cell wall production. This drug is a member of the carboxy group and has high resistance to bacteria that have become resistant to penicillin, Erythromycin, or Tetracycline antibiotics. Ceftiofur chloride is a cephalosporin antibacterial. Ceftiofur hydrochloride is the active ingredient of ceftiofur tablets. It's used to treat bacterial infections in cattle and poultry. Ceftiofur is a first-generation antibiotic for treating human diseases such as pneumonia or other infections like meningitis and tuberculosis.

Ceftiofur, an antibiotic, is part of the cephalosporins family. Ceftiofur has a wide range of activities. It can be administered as an intravenous injection, or as an aerosol or single-dose nebulized spray. This helps to break down mucus. Ceftiofur can be administered in hospitals to patients who are unable or unable to breathe by themselves. This includes those suffering from asthma attacks, chronic obstructive lung disease (COPD), and accident victims. It is used often to treat infections of the urinary tract. Ceftiofur kills bacteria in the urine and prevents its recurrence. Pregnant women can be treated with this medication if they have a suspicion of having a kidney infection. Ceftiofur is a member of the cephalosporins group. It works by disrupting bacteria's cell walls, making them less able to divide. This eventually leads to their death. Ceftiofur can be used to treat bovine interdigital Necrobacillosis. Bovine interdigital necrobacillosis, also known as "foot disease" or "hoof disease", is a condition that causes chronic lameness and hoof lesion formation. This can lead to infection. Hydrochloride helps fight bacteria by killing them through its effect on bacterial cell membranes; this will help prevent stress-induced laminitis and allow for reestablishing of healthy foot tissue. The semisynthetic cephalosporin ceftiofur is beta-lactamase-stable, broad-spectrum, and antibacterial. Ceftiofur inactivates and binds penicillin-binding proteins (PBPs), which are located on the inner membranes of bacterial cell walls. PBPs are involved in the final stages of assembling the bacterial cell wall as well as in shaping the cell wall during division and growth. PBPs are inactivated, which causes a disruption to the cross-linking of peptidoglycan chain peptidoglycan chains that is necessary for the strength and rigidity of the bacterial cell walls. Cell lysis is caused by the weakening and destabilization of bacterial cell walls.
It is resistant to hydrolysis with beta-lactamase and has activity against both Gram-positive and Gram negative bacteria. There have been reports of E.coli strains that are resistant to ceftiofur. Desfurolyceftiofur, a metabolite of ceftiofur, also has antibiotic activity. Therefore, the two compounds are combined to measure antibiotic activity in milk.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Cetiofur Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Cetiofur Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Hipra
  • Zoetis Inc.
  • MerckCo., Inc., (MSD Animal Health)
  • Ceva Sante Animale
  • Hester Biosciences Limited
  • Bayer AG
  • Cephazone Pharma LLC
  • Ceva Sant Animale

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Drug Type

  • Ceftiofur Sodium
  • Ceftiofur Hydrochloride
  • Ceftiofur Crystalline Free Acid

By Animal Type

  • Cattle
  • Horse
  • Swine
  • Others

By Application

  • Respiratory Infections
  • Urinary Tract Infections
  • Bovine Interdigital Necrobacillosis
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Cetiofur Market By Drug Type, By Animal Type, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Cetiofur Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cetiofur Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Cetiofur Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Cetiofur Market, By Drug Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Ceftiofur Sodium
        2. Ceftiofur Hydrochloride
        3. Ceftiofur Crystalline Free Acid

  • 8.   Cetiofur Market, By Animal Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cattle
        2. Horse
        3. Swine
        4. Others

  • 9.   Cetiofur Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Respiratory Infections
        2. Urinary Tract Infections
        3. Bovine Interdigital Necrobacillosis
        4. Others

  • 10.   North America Cetiofur Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Cetiofur Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Cetiofur Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Cetiofur Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Hipra
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Zoetis Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. MerckCo., Inc., (MSD Animal Health)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Ceva Sante Animale
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Hester Biosciences Limited
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Bayer AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Cephazone Pharma LLC
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Ceva Sant Animale
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients